Analyst Price Target is $11.50
▲ +119.89% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Viemed Healthcare in the last 3 months. The average price target is $11.50, with a high forecast of $14.00 and a low forecast of $9.00. The average price target represents a 119.89% upside from the last price of $5.23.
Current Consensus is
The current consensus among 3 polled investment analysts is to buy stock in Viemed Healthcare.
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore on December 14, 2016 and is headquartered in Lafayette, LA.